Aclatonium napadisilate
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151520This classification denotes a cholinergic agonist with the molecular formula 2C10H20NO4.C10H6O6S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YX23434YHQ, chemically known as 2-(2-(acetyloxy)-1-oxopropoxy)-n,n,n-trimethylethanaminium, 1,5-naphthalenedisulfonate (2:1) but generally known as aclatonium napadisilate, which bears US NIH Compound Identifier 41315. European Medicines Agency schedules Aclatonium napadisilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05244MIG. The term ACLATONIUM NAPADISILATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). Most nations schedule aclatonium napadisilate under HS 29239000 and SITC 51481. As of Q4 2014, ACLATONIUM NAPADISILATE remains the US FDA Preferred Term for this commodity. Aclatonium napadisilate bears US NLM identifiers UMLS ID C0076758 and NCI Concept Code C91037. SMILES: CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.CC(C(=O)OCC[N+](C)(C)C)OC(=O)C.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-].
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.